v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Common Stock Activity
The following table summarizes the Company’s common stock option activity for the three months ended March 31, 2026:
Number of
Common
Stock
Options
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
Aggregate
Intrinsic Value
(in years)(in thousands)
Outstanding as of December 31, 20255,767,799$12.01 8.3$168,007 
Granted1,807,54739.20 
Exercised(352,066)6.32 
Cancelled or forfeited(97,490)16.40 
Outstanding as of March 31, 20267,125,790$19.13 8.5$149,390 
Exercisable as of March 31, 20262,283,841$9.45 7.4$69,988 
Schedule of Stock-Based Compensation
During the three months ended March 31, 2026, and 2025, the Company recorded stock-based compensation in the accompanying condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

Three Months Ended
March 31,
20262025
Research and development expense
$2,020 $804 
General and administrative expense
4,533 1,290 
Total
$6,553 $2,094